Declining EBIT MarginA falling EBIT margin points to rising costs, pricing pressure or operational inefficiencies. Continued margin compression would reduce operating profits and cash generation, constraining reinvestment and dividend capacity and posing a sustained challenge to profitability restoration.
Free Cash Flow VariabilityRecent declines and variability in free cash flow create uncertainty around funding of capex and distributions. If this volatility persists, management may need to conserve cash or access external financing, which would weaken flexibility and could delay strategic investments.
Limited Scale (workforce)A relatively small employee base suggests limited internal scale for R&D, production scaling and commercial expansion. In specialty chemicals, constrained headcount can slow product development, capacity ramp-ups and broader geographic growth, limiting competitive reach over the medium term.